+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ablynx - logo

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, oncology, and respiratory diseases. The company was formerly known as MatchX and changed its name to Ablynx NV in June 2002. Ablynx NV was founded in 2001 and is headquartered in Ghent, Belgium.

Candidiasis Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Candidiasis Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 111 Pages
  • Global
From
Bone Cancer Diagnosis and Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Bone Cancer Diagnosis and Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 108 Pages
  • Global
From
Nano Chemotherapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Nano Chemotherapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2023
  • 92 Pages
  • Global
From
Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion - Product Thumbnail Image

Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion

  • Report
  • July 2020
  • 51 Pages
  • Global
From
Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Competitor Landscape: Rheumatoid Arthritis - Product Thumbnail Image

Competitor Landscape: Rheumatoid Arthritis

  • Report
  • October 2018
  • 71 Pages
  • Global
From
Global Tumor Necrosis Factor Inhibitors Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024 - Product Thumbnail Image

Global Tumor Necrosis Factor Inhibitors Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • Report
  • March 2018
  • 300 Pages
  • Global
From
Bone Metastasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Bone Metastasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 124 Pages
  • Global
From
Ablynx NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Ablynx NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Recent Collaborations in Biotech - Product Thumbnail Image

Recent Collaborations in Biotech

  • Report
  • February 2018
  • 15 Pages
  • Global
Ablynx NV - Strategic SWOT Analysis Review - Product Thumbnail Image

Ablynx NV - Strategic SWOT Analysis Review

  • SWOT Analysis
  • December 2021
  • 25 Pages
From
Loading Indicator